Salarius Pharmaceuticals, Inc. stock is traded on the Nasdaq Stock Market under the ticker symbol SLRX. Salarius Pharmaceuticals, Inc. is in the Biotechnology & Medical Research industry.
Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing treatments for parties with cancers in need of new treatment options. Its product portfolio includes seclidemstat, an oral novel small molecule inhibitor of the LSD1 enzyme and the Company's lead candidate, which is being studied as a potential treatment for pediatric cancers, sarcomas, and other cancers with limited treatment options, and SP-3164, an oral small molecule protein degrader being developed for the treatment of Non-Hodgkins Lymphoma. SP-3164 is a small molecule protein degrader, and seclidemstat (SP-2577) is a small molecule inhibitor. SP-3164 is a next-generation cereblon-binding molecular glue (MG). SP-2577 is a small-molecule LSD1 inhibitor with a novel scaffold. The molecule was discovered using structure-based computational screening coupled with chemical screening and further optimization with structure-activity relationship studies.
Stock Ticker Symbol Lookup
Here you can look up another stock ticker symbol.
Stock Ticker Symbol QNRX
Here is another stock ticker symbol that we have information about!
Contact | Disclaimer | Copyright | Privacy